Federated Hermes
MRVI icon

Federated Hermes’s Maravai LifeSciences MRVI Stock Holding History

Federated Hermes’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-44,807
Closed -$293K – 2100
2023
Q4 		$293K Sell
44,807
-189,696
-81% -$1.23M ﹤0.01% 1456
2023
Q3 		$2.35M Buy
234,503
+22,027
+10% +$242K 0.01% 874
2023
Q2 		$2.64M Sell
212,476
-13,148
-6% -$177K 0.01% 869
2023
Q1 		$3.16M Sell
225,624
-18,262
-7% -$262K 0.01% 813
2022
Q4 		$3.49M Buy
243,886
+186,467
+325% +$2.94M 0.01% 761
2022
Q3 		$1.47M Buy
57,419
+21,016
+58% +$527K ﹤0.01% 998
2022
Q2 		$1.03M Buy
36,403
+36,036
+9,819% +$1.14M ﹤0.01% 1134
2022
Q1 		$13K Sell
367
-23,360
-98% -$783K ﹤0.01% 1867
2021
Q4 		$994K Sell
23,727
-63,614
-73% -$2.58M ﹤0.01% 1276
2021
Q3 		$4.29M Buy
87,341
+37,599
+76% +$1.83M 0.01% 856
2021
Q2 		$2.08M Buy
+49,742
New +$1.93M ﹤0.01% 1084
2021
Q1 		– Sell
-20,000
Closed -$561K – 2311
2020
Q4 		$561K Buy
+20,000
New +$557K ﹤0.01% 1498

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federated Hermes's MRVI Position: Q1 2024 in Review

Federated Hermes sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 44,807 shares — an estimated $293K sold.

Federated Hermes first reported a position in MRVI in Q4 2020 and held it in 12 quarters. The position peaked at $4.29M in Q3 2021. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

  • Federated Hermes reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Federated Hermes sold 44,807 Maravai LifeSciences shares in Q1 2024, an estimated $293K.
  • Federated Hermes first reported a position in Maravai LifeSciences in Q4 2020 and held it in 12 quarters.
  • Federated Hermes's Maravai LifeSciences position peaked at $4.29M in Q3 2021.
  • 210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.